456 related articles for article (PubMed ID: 30015868)
1. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.
Wang Y; Yan L; Zhang L; Xu H; Chen T; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
Int J Oncol; 2018 Sep; 53(3):1043-1054. PubMed ID: 30015868
[TBL] [Abstract][Full Text] [Related]
2. N-peptide of vMIP-Ⅱ reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer.
Wang Y; Wang H; Ding Y; Li Y; Chen S; Zhang L; Wu H; Zhou J; Duan K; Wang W; Chen C; Yang Q
Int J Oncol; 2017 Sep; 51(3):918-930. PubMed ID: 28731125
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism.
Yang QL; Zhang LY; Wang HF; Li Y; Wang YY; Chen TT; Dai MF; Wu HH; Chen SL; Wang WR; Wu Q; Chen CJ; Zhou CZ
Oncotarget; 2017 Jun; 8(23):37448-37463. PubMed ID: 28415580
[TBL] [Abstract][Full Text] [Related]
5. Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer.
Yang Q; Zhang F; Ding Y; Huang J; Chen S; Wu Q; Wang Z; Wang Z; Chen C
Br J Cancer; 2014 Mar; 110(5):1288-97. PubMed ID: 24448360
[TBL] [Abstract][Full Text] [Related]
6. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal polypeptide derived from vMIP-II exerts its antitumor activity in human breast cancer through CXCR4/miR-7-5p/Skp2 pathway.
Wang HF; Dong ZY; Yan L; Yang S; Xu HN; Chen SL; Wang WR; Yang QL; Chen CJ
J Cell Physiol; 2020 Dec; 235(12):9474-9486. PubMed ID: 32372405
[TBL] [Abstract][Full Text] [Related]
8. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
[TBL] [Abstract][Full Text] [Related]
9. MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.
Yang Q; Wang Y; Lu X; Zhao Z; Zhu L; Chen S; Wu Q; Chen C; Wang Z
Oncotarget; 2015 Feb; 6(5):3268-79. PubMed ID: 25605244
[TBL] [Abstract][Full Text] [Related]
10. Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer.
Wang W; Zhang L; Wang Y; Ding Y; Chen T; Wang Y; Wang H; Li Y; Duan K; Chen S; Yang Q; Chen C
Cell Death Dis; 2017 Oct; 8(10):e3071. PubMed ID: 28981108
[TBL] [Abstract][Full Text] [Related]
11. MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.
Zhang L; Chen T; Yan L; Xu H; Wang Y; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
Gene; 2019 Jun; 700():85-95. PubMed ID: 30878390
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
Cheng L; Xing Z; Zhang P; Xu W
Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
[TBL] [Abstract][Full Text] [Related]
14. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.
Liu MM; Li Z; Han XD; Shi JH; Tu DY; Song W; Zhang J; Qiu XL; Ren Y; Zhen LL
Sci Rep; 2017 Nov; 7(1):15929. PubMed ID: 29162879
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract][Full Text] [Related]
17. Suppression of breast cancer proliferation and induction of apoptosis via AKT and ERK1/2 signal transduction pathways by synthetic polypeptide derived from viral macrophage inflammatory protein II.
Yang Q; Chen C; Yang Z; Gao Y; Tang J
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):497. PubMed ID: 21823011
[TBL] [Abstract][Full Text] [Related]
18. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
19. [The mechanism of polypeptide derived from viral macrophage inflammatory protein II modulates SDF-1α/CXCR4-induced migration].
Yang QL; Ding YX; Chen CJ; Yang ZF; Gao YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):137-40. PubMed ID: 22304770
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
